Skip to main content
BCWORLDPHARM Co., Ltd. logo

BCWORLDPHARM Co., Ltd. — Investor Relations & Filings

Ticker · 200780 ISIN · KR7200780005 KO Manufacturing
Open in API
Filings indexed 192 across all filing types
Latest filing 2020-12-11 Declaration of Voting R…
Country KR South Korea
Listing KO 200780

About BCWORLDPHARM Co., Ltd.

https://www.bcwp.co.kr

BCWORLDPHARM Co., Ltd. is a technology-driven pharmaceutical company specializing in the research, development, and manufacturing of prescription drugs. The company leverages its core expertise in formulation and process development to produce a diverse portfolio of quality generic medicines. With a significant commitment to research and development, BCWORLDPHARM focuses on creating next-generation pharmaceuticals to address evolving medical needs and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short regulatory announcement regarding the closure of the shareholder register for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal notice of a corporate action. Given it is a regulatory announcement that does not fit into specific categories like dividend or share issuance, it is classified as a general regulatory filing.
2020-12-11 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'BCWORLD PHARM' (주식회사 비씨월드제약) covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial data, business descriptions, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-13 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 비씨월드제약' covering the period from 2020-01-01 to 2020-06-30. It contains detailed financial statements, management discussion, and business operations data, which fits the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed in Korea. This type of filing is required when an entity's shareholding in a company crosses certain thresholds (typically 5%). In the context of the provided categories, this corresponds to a 'Major Shareholding Notification' (MRQ), which tracks changes in significant ownership levels.
2020-07-10 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 비씨월드제약' (BCWORLD PHARM. Co., Ltd.) covering the period from 2020-01-01 to 2020-03-31. It contains detailed financial information, company overview, business operations, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-14 Korean
[기재정정]기타경영사항(자율공시)(상환전환우선주의 보통주 전환청구)
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from BC World Pharm regarding the conversion of redeemable convertible preferred shares into common shares. It details the number of shares converted, the conversion ratio, and the resulting change in the company's capital structure (share count). Since this involves a change in the company's capital structure and share issuance, it falls under the 'Share Issue/Capital Change' category.
2020-05-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.